Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
British Journal of Clinical Pharmacology
|
January 1, 1982
Long-term experience of captopril in the treatment of primary (essential) hypertension
B E Karlberg, J Asplund, S Wettre, et al.
Blood Pressure
|
November 1, 1996
A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome
F Nyström, P Nilsson, A G Olsson, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum
|
January 1, 1984
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report
B E Karlberg, F Fyhrquist, C Grönhagen-Riska, et al.
Acta Medica Scandinavica
|
January 1, 1981
Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity
B E Karlberg, J Asplund, O R Nilsson, et al.
Virology
|
March 10, 1995
Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus
A Samuelsson, F Chiodi, P Ohman, et al.
Acta Medica Scandinavica
|
January 1, 1985
Long-term effects of captopril and atenolol in essential hypertension
L Andrén, B E Karlberg, A Svensson, et al.
Clinical Endocrinology
|
August 1, 1997
Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment
F Nyström, B Ekman, M Osterlund, et al.
Virology
|
May 1, 1994
Stable biological and antigenic characteristics of HIV-2SBL6669 in nonpathogenic infection of macaques
Y J Zhang, P Putkonen, J Albert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 21, 2004
Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans
H Ericsson, B Hamrén, S Bergstrand, et al.
Virology
|
December 1, 1993
Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis
Y J Zhang, P Ohman, P Putkonen, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
British Journal of Clinical Pharmacology
|
January 1, 1982
Long-term experience of captopril in the treatment of primary (essential) hypertension
B E Karlberg, J Asplund, S Wettre, et al.
Blood Pressure
|
November 1, 1996
A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome
F Nyström, P Nilsson, A G Olsson, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum
|
January 1, 1984
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report
B E Karlberg, F Fyhrquist, C Grönhagen-Riska, et al.
Acta Medica Scandinavica
|
January 1, 1981
Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity
B E Karlberg, J Asplund, O R Nilsson, et al.
Virology
|
March 10, 1995
Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus
A Samuelsson, F Chiodi, P Ohman, et al.
Acta Medica Scandinavica
|
January 1, 1985
Long-term effects of captopril and atenolol in essential hypertension
L Andrén, B E Karlberg, A Svensson, et al.
Clinical Endocrinology
|
August 1, 1997
Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment
F Nyström, B Ekman, M Osterlund, et al.
Virology
|
May 1, 1994
Stable biological and antigenic characteristics of HIV-2SBL6669 in nonpathogenic infection of macaques
Y J Zhang, P Putkonen, J Albert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 21, 2004
Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans
H Ericsson, B Hamrén, S Bergstrand, et al.
Virology
|
December 1, 1993
Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis
Y J Zhang, P Ohman, P Putkonen, et al.
Page
of 7